A Randomized Phase Ⅱ Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Pl

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:god_save_me
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的: Mucosal melanoma is rare in Caucasian population but account for 25% in Asian population.It is usually associated with extremely poor prognosis.No standard treatment for advanced mucosal melanoma has been established.
其他文献
目的 提高对卡梅综合征的临床治疗效果 方法 2010年-2014年苏州大学附属儿童医院整形外科收治13例KMS患儿,分析该病的病因,临床表现、诊断、治疗及预后。结果 KMS病因不明,病理生理基础是血小板减少和弥漫性血管内凝血(DIC)。临床表现多样化。根据具体情况选择应用普萘洛尔联合治疗。结论 卡梅综合征一旦诊断明确,在对症治疗的基础上及时应用普萘洛尔治疗,临床疗效明显。
Objective: To achieve this objective, we designed, developed and tested an intelligent pain management system (IPMS) to facilitate real-time pain recording and intervention in Chinese cancer pain pati
Objective: The routine integration of early involvement of palliative care in advanced cancer management is not yet a part of standard practice in many countries, including Mainland China.
Objective: To evaluate whether the traditional Chinese medicine Yi Shen Jian Gu granules (YSJG) is effective to relieve aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in patients with
Objective: Capecitabine (Cape) maintenance therapy after response to Cape-based combination chemotherapy (CT) is one of the standard regimens recommended by NCCN for metastatic breast cancer (MBC) tre
目的:1.探讨沙利度胺联合盐酸羟考酮缓释片治疗中、重度癌痛的有效性和安全性;2.观察沙利度胺联合盐酸羟考酮缓释片对癌痛患者的生活质量、睡眠质量改善情况,以及患者便秘、嗜睡、恶心、呕吐,静脉血栓等不良反应发生情况;3.观察沙利度胺对晚期癌痛患者的恶液质改善情况.
目的:研究CIK结合消岩汤治疗放弃放化疗肺癌的疗效及安全性。方法:选择60例放弃放化疗治疗的肺癌患者,采用CIK结合消岩汤进行治疗,并对治疗前后疗效、生活质量、相关实验室检查进行比较。
目的:明确吗啡快速滴定治疗中、重度癌痛时,持续静脉泵入法是否优于口服方法。方法:选取在我院肿瘤科住院并伴有NRS≥4分的癌性疼痛患者进行吗啡快速滴定,采用平行、随机、对照方法分成口服组和静脉组。如果患者对吗啡口服或注射给药有抵触,可调整至另外一组。
目的: A phase Ⅱ study has revealed that rh-Endostatin (Endostar) was more effective when combining with dacarbazine (DTIC) for metastatic melanoma patients (pts) with good tolerance especially for acral
会议
Objective: Advances in medical oncology, surgical technique, and prosthesis design have considerably increased the longevity of endoprosthesis replacements after tumor resection.